KATHLEEN HERZOG: Open Payments
NPI 1881169365 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 81 payments from 15 companies in 2025. Trend: 2023 $1,600 · 2024 $2,292 · 2025 $1,415
Food & beverage: $1,324Education: $92
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $466 |
| Janssen Biotech, Inc. | 11 | $182 |
| Novartis Pharmaceuticals Corporation | 14 | $175 |
| Regeneron Healthcare Solutions, Inc. | 7 | $136 |
| Lilly USA, LLC | 4 | $91 |
| GENZYME CORPORATION | 3 | $60 |
| UCB, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $37 |
Products named: SKYRIZI, TREMFYA, COSENTYX, DUPIXENT, LIBTAYO, TALTZ, Bimzelx, Sotyktu.
Industry payments across WA — which companies pay providers there.
